Improving Localization of AMP Delivery By Engineering Pathogen-Binding Commensal Bacteria

Hackel, B. J., University of Minnesota
Antibiotic resistant pathogens pose a significant public health challenge due to decreasing availability of functional antibiotics. Of these pathogens, vancomycin-resistant Enterococcus (VRE) infections are especially detrimental due to increased mortality and escalating nosocomial costs. An emerging treatment option is to utilize antimicrobial peptides (AMPs) to fight infection. However, AMP delivery is complicated by proteases found in the stomach. To combat this problem, commensal bacteria can be engineered to locally produce AMPs, thus avoiding degradation. This approach requires delivery of the engineered probiotic bacteria to the site of pathogenic infection.

We propose to improve localization of AMP delivery by engineering the probiotic cell surface to ‘display’ VRE-binding ligands. Motivated by the known strain specificity of endolysin binding domains, we identified potential secreted endolysins that selectively bind VRE, found on VRE-specific lytic viruses. We queried the BLAST NR database to differentiate the catalytic and binding domains of endolysins. S. cerevisiae yeast were engineered to display these endolysins – both as complete proteins and as the isolated binding domains – for directed evolution of specificity and affinity towards select VRE strains using magnetic and flow cytometric selections with biotinylated VRE. Because the parameter space is too large to test all possible mutations, the binding paratope will be identified via mutational mapping strategies. The paratope will then be mutated via a focused combinatorial library design to conserve intramolecularly critical residues while enabling functional diversity at complementarity-determining sites.

In parallel, we are engineering Lactococcus lactis for cell surface display of engineered endolysins. To do this, we are utilizing existing secretion mechanisms (Sec1) in L. lactis to secrete and attach endolysins to the cell surface. Our approach is to add a conserved cell wall anchor sequence (LPXTG) to the binder, which enables covalent conjugation to the cell wall via the sortase enzyme. After the binder is expressed on L. lactis, the efficacy of AMP delivery method will be compared to L. lactis without binder expression.